ARCHIVES

NCI Advisory Group, Other Cancer Meeting

This article is from The Cancer Letter archive.

Vol. 04 No. 21 | May 26, 1978

Download PDF Visit The Full Archive

Related Articles

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005